Synonyms: Campral®
acamprosate is an approved drug (FDA (2004))
Compound class:
Synthetic organic
Comment: Acamprosate is a NMDA glutamate receptor antagonist and a positive allosteric modulator of GABAA receptors.
Marketed formulations contain acamprosate calcium (PubChem CID 155434). View more information in the IUPHAR Pharmacology Education Project: acamprosate |
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2004)) |
IUPAC Name |
N-(3-sulfopropyl)ethanimidic acid |
International Nonproprietary Names | |
INN number | INN |
6473 | acamprosate |
Synonyms |
Campral® |
Database Links | |
CAS Registry No. | 77337-76-9 |
ChEBI | CHEBI:51041 |
ChEMBL Ligand | CHEMBL1201293 |
DrugBank Ligand | DB00659 |
DrugCentral Ligand | 38 |
GtoPdb PubChem SID | 178103683 |
PubChem CID | 71158 |
Search Google for chemical match using the InChIKey | AFCGFAGUEYAMAO-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | AFCGFAGUEYAMAO |
Search PubMed clinical trials | acamprosate |
Search PubMed titles | acamprosate |
Search PubMed titles/abstracts | acamprosate |
UniChem Compound Search for chemical match using the InChIKey | AFCGFAGUEYAMAO-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | AFCGFAGUEYAMAO-UHFFFAOYSA-N |
Wikipedia | acamprosate |